Joshua B. Rubin
- Genetics top 0.5%
- Glioma Diagnosis and Treatment 54
- Developmental Neuroscience top 1%
- Oncology top 1%
- Chemokine receptors and signaling 12
- Neurology top 1%
- Neurofibromatosis and Schwannoma Cases 15
- Neuroblastoma Research and Treatments 11
- Immunology top 2%
-
- Epigenetics and DNA Methylation 17
- Histone Deacetylase Inhibitors Research 9
-
- Sex and Gender in Healthcare 15
-
- Meningioma and schwannoma management 10
- Co-authors
- Robyn S. KleinRosalind A. SegalNicole M. WarringtonAndrew D. LusterSabra L. KleinJames R. ConnorTao SunDavid H. Gutmann
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (2 papers)The Lancet (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Joshua B. Rubin
154 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Genetics 1.7k
- Developmental Neuroscience 414
- Oncology 1.8k
- Neurology 552
- Immunology 1.3k
Countries citing papers authored by Joshua B. Rubin
This map shows the geographic impact of Joshua B. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua B. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua B. Rubin more than expected).
Fields of papers citing papers by Joshua B. Rubin
This network shows the impact of papers produced by Joshua B. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua B. Rubin. The network helps show where Joshua B. Rubin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joshua B. Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 11 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 21 | |
| 6 | 2021 | 28 | |
| 7 | 2021 | 10 | |
| 8 | 2020 | 28 | |
| 9 | 2019 | 214 | |
| 10 | 2018 | 81 | |
| 11 | 2011 | 33 | |
| 12 | 2011 | 48 | |
| 13 | 2010 | 87 | |
| 14 | 2008 | 397 | |
| 15 | 2008 | 105 | |
| 16 | 2008 | 158 | |
| 17 | 2007 | 115 | |
| 18 | 2007 | 87 | |
| 19 | 2005 | 96 | |
| 20 | A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumorsbreakdown → | 2003 | 511 |
About Joshua B. Rubin
Joshua B. Rubin is a scholar working on Genetics, Neurology and Developmental Neuroscience, having authored 160 papers that have together received 8.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (54 papers), Epigenetics and DNA Methylation (17 papers), Sex and Gender in Healthcare (15 papers), Neurofibromatosis and Schwannoma Cases (15 papers), Chemokine receptors and signaling (12 papers), Neuroblastoma Research and Treatments (11 papers), Meningioma and schwannoma management (10 papers) and Histone Deacetylase Inhibitors Research (9 papers). The work is most often cited by research in Genetics (1.7k citations), Developmental Neuroscience (414 citations) and Oncology (1.8k citations). Joshua B. Rubin has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Robyn S. Klein, Rosalind A. Segal, Nicole M. Warrington, Andrew D. Luster, Sabra L. Klein, James R. Connor, Tao Sun, David H. Gutmann, B. Mark Woerner and Richard E. Fine. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.